Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia.
Rocha V, Arcuri LJ, Seber A, Colturato V, Zecchin VG, Kuwahara C, Nichele S, Gouveia R, Fernandes JF, Macedo AV, Tavares R, Daudt L, De Souza MP, Darrigo-Jr LG, Villela NC, Mariano LCB, Ginani VC, Zanette A, Loth G, Gomes AA, Hamerschlak N, Flowers ME, Bonfim C; Paediatric Working Group and the Brazil-Seattle Consortium Study Group (GEDECO) of the Brazilian Bone Marrow Transplantation Society (SBTMO).
Rocha V, et al. Among authors: daudt l.
Bone Marrow Transplant. 2021 Dec;56(12):3042-3048. doi: 10.1038/s41409-021-01453-0. Epub 2021 Sep 21.
Bone Marrow Transplant. 2021.
PMID: 34548627